Immunoglobulins and hyposensitization for allergy

Area of Science:

• Immunology
• Allergy Research
• Oncoimmunology

Background:

• The human immune system's response to prolonged stimulation is investigated for its potential role in malignant immunocytopathies.
• Allergy immunotherapy (hyposensitization) involves protracted immune system stimulation.

Purpose of the Study:

• To scrutinize the premise that prolonged immune stimulation during allergy hyposensitization might induce malignant immunocytopathies.
• To compare serum immunoglobulin levels between allergic patients undergoing hyposensitization and control groups.

Main Methods:

• Serum immunoglobulin levels (specifically IgG) were analyzed in 313 allergic patients undergoing hyposensitization.
• These levels were compared with those of 138 nonallergic individuals and 189 allergic individuals not receiving hyposensitization.
• Historical data from all study groups were critically evaluated.

Main Results:

• Significant differences were observed in mean total immunoglobulin G (IgG) levels between allergic hyposensitized patients and the non-allergic control group.
• Hyposensitization was associated with a depression in serum IgG concentration.
• The observed depression in IgG levels correlated with the duration of the hyposensitization program and its continuity (continuous vs. interrupted).

Conclusions:

• The study found that allergy hyposensitization significantly alters serum IgG levels, leading to a depression in concentration.
• These alterations are related to the duration and nature of the desensitization program.
• While one case of evolving monoclonal immunocytopathy was noted, its direct etiology remains unestablished in this study.